40 Results for "

interleukin-5

" in MedChemExpress (MCE) Product Catalog:
Products (40)

40 Results for "interleukin-5" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-P700215AF
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: interleukin-5; IL-5; B-cell differentiation factor I; EosinophIL differentiation factor; T-cell replacing factor; TRF; IL5
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P70612
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: interleukin-5; IL-5; B-cell differentiation factor I; Eosinophil differentiation factor; T-cell replacing factor; TRF; IL5
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P9923A
CAS No.: 1044511-01-4
Synonyms: MEDI-563 (anti-IL5RA ); BIW-8405 (anti-IL5RA )
Benralizumab (anti-IL5RA ) (MEDI-563 (anti-IL5RA ); BIW-8405 (anti-IL5RA)) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma study .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P9923
CAS No.: 1044511-01-4
Synonyms: MEDI-563; BIW-8405; KHK4563
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P7081
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rMuIL-5; EDF; BCDFII; TRF
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P7102
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rRtIL-5; EDF; BCDFII; TRF
Species:  
Rat
Source:  
loading...
    loading...
Cat. No.: HY-P9945
CAS No.: 196078-29-2
Synonyms: SB 240563
Mepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma .
loading...
    loading...
Cat. No.: HY-P9945A
CAS No.: 196078-29-2

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Mepolizumab (anti-IL5) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma .
loading...
    loading...
Cat. No.: HY-P990774
CAS No.: 2768386-15-6
Synonyms: ASP-7266; TRAB-1; UPB-101

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Verekitug (ASP-7266; TRAB-1; UPB-101) is a human monoclonal antibody targeting the thymic stromal lymphopoietin receptor (TSLPR), with a mean half-life of approximately 20 days. At doses of Verekitug ≥100 mg, complete and sustained TSLPR-specific occupancy is achieved, and the antibody does not bind to IL-7Rα. By inhibiting TSLP-driven inflammatory responses, Verekitug blocks TSLP-induced cell proliferation and TARC expression, while reducing fractional exhaled NO levels, blood eosinophil counts, and levels of IL-5 and IgE. Verekitug significantly improves scores for nasal polyps, nasal congestion and olfactory dysfunction, with favorable safety and good tolerability; potential adverse reactions include headache, upper respiratory tract infection, sinusitis and nasopharyngitis. Verekitug is used in relevant studies on asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease .
loading...
    loading...
Cat. No.: HY-P9949
CAS No.: 241473-69-8
Synonyms: Sch 55700; CDP-835; JES1-39D10

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Reslizumab (Sch 55700) is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. Reslizumab is effective in neutralizing the function of IL-5. Reslizumab has high binding affinity for human IL-5, with KD values of 109 pM and 4.3 pM in the the Biacore surface plasmon resonance and Kinetic Exclusion Assay, respectively .
loading...
    loading...
Cat. No.: HY-P78608
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IL-5; TRF; IL5; interleukin-5
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P78314
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: interleukin-5; IL-5; T-cell replacing factor; TRF; EDF
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P73219
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: interleukin-5; IL-5; EDF; Eo-CSF; TRF
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P73218
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: interleukin-5; IL-5; EDF; Eo-CSF; TRF
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P73878
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: interleukin-5; IL-5; EDF; Eo-CSF; TRF
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P704717
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: interleukin-5; IL-5; EDF; Eo-CSF; TRF
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P78155
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: interleukin-5; IL-5; T-cell replacing factor; TRF; EDF
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P71630
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IL5; interleukin-5; IL-5; Eosinophil differentiation factor; T-cell replacing factor; TRF
Species:  
Pig
Source:  
loading...
    loading...
Cat. No.: HY-P991144
CAS No.: 3021525-26-5

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Lasrekibart is a humanized monoclonal antibody targeting human interleukin 5 (IL-5). Lasrekibart specifically binds to IL-5, blocking the interaction between IL-5 and its receptor, thus exerting immunosuppressive and anti-inflammatory activities. Lasrekibart is promising for research of allergic and inflammatory diseases, such as asthma .
loading...
    loading...
Cat. No.: HY-P704394
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: interleukin-5; B-cell differentiation factor I; EosinophIL differentiation factor; T-cell replacing factor; TRF; IL5
Species:  
Source:  
loading...
    loading...